Predictions
Akari Therapeutics plc ADR
Start price
Target price
Perf. (%)
€1.29
07.09.20
07.09.20
-
04.11.21
04.11.21
3.88%
15.07.21
15.07.21
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€9.40
06.08.20
06.08.20
-
04.11.21
04.11.21
90.43%
15.07.21
15.07.21
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€5.70
18.10.20
18.10.20
€2.00
04.11.21
04.11.21
-35.79%
26.06.21
26.06.21
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
GW Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€80.50
24.03.20
24.03.20
€180.00
04.11.21
04.11.21
127.33%
24.06.21
24.06.21
AstraZeneca plc
Start price
Target price
Perf. (%)
€95.39
20.08.20
20.08.20
€105.50
04.11.21
04.11.21
1.68%
14.06.21
14.06.21
Future proof or reliable business model
Small cyclical dependencies
Known brand
Astrazeneca ADR
Start price
Target price
Perf. (%)
€41.60
17.12.20
17.12.20
€48.00
17.12.21
17.12.21
9.86%
03.06.21
03.06.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
GW Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€178.00
26.02.21
26.02.21
-
26.02.22
26.02.22
2.81%
29.05.21
29.05.21
Oxford BioMedica PLC
Start price
Target price
Perf. (%)
€7.20
01.12.19
01.12.19
€8.00
04.11.21
04.11.21
81.94%
26.05.21
26.05.21
Advanced Medical Solutions Group plc
Start price
Target price
Perf. (%)
€2.32
20.03.20
20.03.20
€3.80
04.11.21
04.11.21
36.21%
24.05.21
24.05.21
AstraZeneca plc
Start price
Target price
Perf. (%)
€87.23
20.01.21
20.01.21
-
20.01.22
20.01.22
-1.82%
29.03.21
29.03.21
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Standard Investments for future growth